Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Market Study on Soft Tissue Repair: Paradigm Shift from Conventional Technologies to Use of Biologics is Expected to Drive Market Growth By 2024

Reportlinker
Posted on: 02 Nov 16

PR Newswire

NEW YORK, Nov. 2, 2016

NEW YORK, Nov. 2, 2016 /PRNewswire/ -- This Persistence Market Research (PMR) report examines the global soft tissue repair market for the period 2015–2024. The primary objective of the report is to offer updates and information related to market opportunities in the global soft tissue repair market.

REPORT DESCRIPTION

This Persistence Market Research (PMR) report examines the soft tissue repair market for the period 2015–2024. The primary objective of the report is to offer insights into developments in the soft tissue repair market affecting various segments of the global soft tissue repair market.

Soft tissue injury refers to the damage of muscles, ligaments and tendons occurred through direct and indirect trauma which is commonly characterized by tissue rapture, sprain and wear and tear. Soft tissue repair refers to the surgical procedure for repairing the damaged muscles, ligaments and other tissues. The repair process entails usage of biological materials such as allografts, xenografts, and synthetic mesh, to assist in tissue healing. Soft tissue repair processes are performed in hospitals, ambulatory surgical centers, and clinics.

Increasing incidence of osteoporosis-related factures among the geriatric population is expected to fuel demand for orthopedic surgeries. Moreover, medical expenses related to obesity have increased significantly over the last decade due to active lifestyle trends, which has resulted in increased implant volumes. Soft tissue repair product manufacturers are focused on increasing operations in developed countries of North America and Europe, where geriatric population is rising coupled with high incidence of age-related diseases. Moreover, increasing awareness among physicians about benefits of biological meshes such as reduced cost of surgery and reduced hospital stay post-surgery are expected to boost adoption of soft tissue repair products during the forecast period.

The global soft tissue repair market segmented as follows:

Soft tissue repair market, by product type
Soft tissue repair market, by application
Soft tissue repair market, by end use
Soft tissue repair market, by region

This report covers the global soft tissue repair market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints, and opportunities influencing growth of the global soft tissue repair market.

The soft tissue repair market report begins with an overview of soft tissue repair products, their application, and worldwide adoption of such products. This section emphasizes on influential growth factors of the global soft tissue repair market along with detailing of key trends, drivers, restraints, opportunities, and regulations. Impact analysis of key growth drivers and restraints based on the weighted average model along with key region-specific trends are included in the report to equip clients with crystal-clear and decision-making insights.

On the basis of product type, the global soft tissue repair market is segmented into synthetic, allografts, xenografts, and alloplast. On the basis of application, the global soft tissue market is segmented into breast reconstruction, hernia repair, vaginal sling, dental problems, dermatology, orthopedics, and others. Orthopedics segment is further sub-segmented into dural repair, sports medication and tendon reinforcement, and others. On the basis of end users, the global soft tissue repair market is segmented into hospitals, ambulatory surgical centers, and clinics. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index, and BPS analysis. By product type, allografts segment is expected to register significant growth over the forecast period, owing to increasing adoption of allografts among physicians to treat patients.

The next section of the report highlights growth trends of the soft tissue repair market by regions. It provides a market outlook for 2015–2024 and sets the forecast within the context of the soft tissue repair market. The study discusses key regional trends contributing to growth of the soft tissue repair market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). North America is expected to emerge as the most dominant and attractive market over the forecast period.

The above sections by product type, application, end user, and region evaluate the present scenario and growth prospects of the soft tissue repair market for the period 2015–2024. We have considered 2014 as the base year and provided data for the forecast period.

Detailed company profiles include company-specific long- and short-term strategies, key offerings, and recent developments in the global soft tissue repair market. Key competitors covered in terms of manufacturers include B. Braun Melsungen AG, Baxter, C. R. Bard, Inc., Johnson & Johnson Private Limited, Stryker, Medtronic, Acera Surgical, Inc., Anthrex, Inc., and Acelity L.P. Inc.
Read the full report: http://www.reportlinker.com/p04257217-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-market-study-on-soft-tissue-repair-paradigm-shift-from-conventional-technologies-to-use-of-biologics-is-expected-to-drive-market-growth-by-2024-300356329.html

SOURCE Reportlinker

PR Newswire
www.prnewswire.com

Last updated on: 02/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.